Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis
Keywords: Familial prostate cancer; Intraductal carcinoma; BRCA2 germline mutations; Patient-derived xenografts; Pathology;